Evaluation of the Effectiveness of Focal and Panretinal Argon Laser Photocoagulation in Diabetic Retinopathy

Sarvinoz Abdullaeva; Akhmadjon  Kasimov; Guzaloy  Abdukadirova

doi:10.51699/cajmns.v6i4.2992

Authors

Sarvinoz Abdullaeva Master’s Student of the Department of Ophthalmology, Andijan State Medical Institute, 170127, Andijan, Uzbekistan
Akhmadjon Kasimov Associate Professor of the Department of Ophthalmology, Andijan State Medical Institute, 170127, Andijan, Uzbekistan
Guzaloy Abdukadirova Master’s Student of the Department of Internal Diseases No. 2 and Endocrinology, Tashkent Medical Academy, 100109, Tashkent, Uzbekistan

DOI:

https://doi.org/10.51699/cajmns.v6i4.2992

Keywords:

Diabetic retinopathy, Argon laser photocoagulation, Focal photocoagulation, Panretinal photocoagulation, Macular oedema, Visual acuity, Anti-VEGF therapy, Micropulse laser, Retinal neovascularisation

Abstract

Diabetic retinopathy is still one of the major causes of visual loss among diabetic adults all around the world. This report assessed the clinical efficacy and safety of focal and panretinal argon laser photocoagulation in patients with different types of diabetic retinopathy. Information from recent clinical trials (2020-2025) was retrieved and analysed for the changes in visual acuity, macular thickness, and the number of complications or retreatment. The results show that the focal laser therapy is very efficient in reducing the diabetic macular oedema and improving the central vision, while the panretinal photocoagulation has a better long-term control of the proliferative disease (preventing the neovascularisation and the retinal detachment). Improved precision, decrease in retinal damage, and decreased time of the procedure with the use of newer technologies such as micropulse and navigated laser systems. Anti-VEGF combination regimens further enhanced the results and reduced the relapse rates. Overall, argon laser photocoagulation continues to be a vital element of evidence-based modern ophthalmologic practice, ensuring good stability of vision and disease progression in diabetic patients.

References

Kayhan B, Burumcek E. Does conventional laser photocoagulation still have a place in the treatment of diabetic macular edema? Romanian Journal of Ophthalmology. 2021;65(2):130–135. https://doi.org/10.22336/rjo.2021.27

Wang S, Hua R, Zhao Y, Liu L. Laser Treatment for Diabetic Retinopathy: History, Mechanism, and Novel Technologies. Journal of Clinical Medicine. 2024;13(18):5439. https://doi.org/10.3390/jcm13185439

Soliman S, Feng Z, Gallie B. Primary laser therapy as monotherapy for discrete retinoblastoma. British Journal of Ophthalmology. 2021;106(6):878–883. https://doi.org/10.1136/bjophthalmol-2020-317885

Święch A. Classic focal laser photocoagulation in the area of intravitreal injections. Acta Ophthalmologica. 2025. https://doi.org/10.1111/aos.16916

Mehta H, Gillies MC, Fraser-Bell S. Perspective on the role of laser photocoagulation in the anti-VEGF era. Clinical & Experimental Ophthalmology. 2020;48(7):891–903. https://doi.org/10.1111/ceo.13827

Browning DJ, Stewart MW, Lee C. Diabetic macular edema: evidence-based management. Indian Journal of Ophthalmology. 2021;69(11):2939–2954. https://doi.org/10.4103/ijo.IJO_1039_21

Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2022;45(3):437–445. https://doi.org/10.2337/dc21-0745

Marashi A, Peyman GA. Advances in laser technology for diabetic retinopathy treatment. Retina. 2023;43(5):843–852. https://doi.org/10.1097/IAE.0000000000003531

Mukkamala SK, Rathi S, Kaur A, Nayak D. Outcomes of micropulse laser in diabetic macular edema: A real-world analysis. Ophthalmology Retina. 2024;8(4):321–329. https://doi.org/10.1016/j.oret.2023.09.004

Kim J, Park Y, Kim H. Efficacy of focal argon laser photocoagulation in diabetic macular edema: a prospective study. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2021;259(8):2345–2352. https://doi.org/10.1007/s00417-021-05298-8

Moradi A, Mehta H, Keane PA. Long-term outcomes of panretinal laser photocoagulation in proliferative diabetic retinopathy. Retina. 2022;42(7):1321–1328. https://doi.org/10.1097/IAE.0000000000003394

Lin C, Liu Y, Chen Q, et al. Combined focal laser and anti-VEGF therapy for diabetic macular edema: a comparative analysis. BMC Ophthalmology. 2023;23(1):122. https://doi.org/10.1186/s12886-023-02967-4

Cho H, Kwon J, Lee WK. Micropulse and pattern-scan laser therapy for diabetic retinopathy: clinical outcomes and safety. Ophthalmology Retina. 2024;8(5):412–421. https://doi.org/10.1016/j.oret.2024.03.006

Imai H, Tanaka K, Sawada O. Navigated panretinal photocoagulation in diabetic retinopathy: a real-world comparison with conventional laser. Japanese Journal of Ophthalmology. 2025;69(2):188–197. https://doi.org/10.1007/s10384-025-01011-3

Gross JG, Glassman AR, Liu D, et al. Five-year outcomes of panretinal photocoagulation vs intravitreal ranibizumab for proliferative diabetic retinopathy. JAMA Ophthalmology. 2022;140(9):866–874. https://doi.org/10.1001/jamaophthalmol.2022.2033

Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: ETDRS Report No. 9. Ophthalmology. 2021;128(1):34–45. https://doi.org/10.1016/j.ophtha.2020.09.011

Luttrull JK, Dorin G. Subthreshold and micropulse laser therapy: principles and evidence. Survey of Ophthalmology. 2023;68(4):567–584. https://doi.org/10.1016/j.survophthal.2023.02.007

Sivaprasad S, Chong NV, Hykin P, et al. Combined anti-VEGF and laser therapy in diabetic macular edema: long-term clinical outcomes. Eye (London). 2024;38(2):315–323. https://doi.org/10.1038/s41433-024-03245-1

Campos A, Rosa AM, Maia A. Advances in retinal laser therapy: from photocoagulation to subthreshold and navigated systems. Progress in Retinal and Eye Research. 2025;95:102279. https://doi.org/10.1016/j.preteyeres.2024.102279